Masakazu Kato

Faculty of Pharmaceutical Sciences,Department of Pharmaceutical SciencesAssistant Professor
Last Updated :2025/10/07

■Researcher basic information

Degree

  • Doctor of Pharmacy, The University of Tokyo, Mar. 2023

Research Keyword

  • Drug Delivery System
  • Proteasome
  • Proteolysis

Field Of Study

  • Life sciences, Molecular biology
  • Life sciences, Clinical pharmacy

■Career

Career

  • Apr. 2023 - Present
    Teikyo Heisei University, Faculty of Pharmaceutical Sciences Department of Pharmaceutical Sciences

■Research activity information

Paper

  • Intrinsic signaling pathways modulate targeted protein degradation.
    Yuki Mori; Yoshino Akizuki; Rikuto Honda; Miyu Takao; Ayaka Tsuchimoto; Sota Hashimoto; Hiroaki Iio; Masakazu Kato; Ai Kaiho-Soma; Yasushi Saeki; Jun Hamazaki; Shigeo Murata; Toshikazu Ushijima; Naoko Hattori; Fumiaki Ohtake
    Nature communications, 02 Jul. 2024
    Targeted protein degradation is a groundbreaking modality in drug discovery; however, the regulatory mechanisms are still not fully understood. Here, we identify cellular signaling pathways that modulate the targeted degradation of the anticancer target BRD4 and related neosubstrates BRD2/3 and CDK9 induced by CRL2VHL- or CRL4CRBN -based PROTACs. The chemicals identified as degradation enhancers include inhibitors of cellular signaling pathways such as poly-ADP ribosylation (PARG inhibitor PDD00017273), unfolded protein response (PERK inhibitor GSK2606414), and protein stabilization (HSP90 inhibitor luminespib). Mechanistically, PARG inhibition promotes TRIP12-mediated K29/K48-linked branched ubiquitylation of BRD4 by facilitating chromatin dissociation of BRD4 and formation of the BRD4-PROTAC-CRL2VHL ternary complex; by contrast, HSP90 inhibition promotes BRD4 degradation after the ubiquitylation step. Consequently, these signal inhibitors sensitize cells to the PROTAC-induced apoptosis. These results suggest that various cell-intrinsic signaling pathways spontaneously counteract chemically induced target degradation at multiple steps, which could be liberated by specific inhibitors.
  • Senescent cells form nuclear foci that contain the 26S proteasome.
    Tomohiro Iriki; Hiroaki Iio; Shu Yasuda; Shun Masuta; Masakazu Kato; Hidetaka Kosako; Shoshiro Hirayama; Akinori Endo; Fumiaki Ohtake; Mako Kamiya; Yasuteru Urano; Yasushi Saeki; Jun Hamazaki; Shigeo Murata
    Cell reports, 01 Aug. 2023
    The proteasome plays a central role in intracellular protein degradation. Age-dependent decline in proteasome activity is associated with cellular senescence and organismal aging; however, the mechanism by which the proteasome plays a role in senescent cells remains elusive. Here, we show that nuclear foci that contain the proteasome and exhibit liquid-like properties are formed in senescent cells. The formation of senescence-associated nuclear proteasome foci (SANPs) is dependent on ubiquitination and RAD23B, similar to previously known nuclear proteasome foci, but also requires proteasome activity. RAD23B knockdown suppresses SANP formation and increases mitochondrial activity, leading to reactive oxygen species production without affecting other senescence traits such as cell-cycle arrest and cell morphology. These findings suggest that SANPs are an important feature of senescent cells and uncover a mechanism by which the proteasome plays a role in senescent cells.

MISC

  • Analysis of the proteostasis in mice with increased proteasome activity by DDI2 overexpression               
    2022
  • The augmentation of the tumor-specific accumulation of live-Bifidobacteria by the enhancing agent for EPR effect.               
    2019
  • TNF-α発現・分泌組換えビフィズス菌のマウス悪性黒色腫モデルを用いたがん免疫療法への応用検討               
    加藤 雅和; 平 裕一郎; 平 郁子; 清水 芳実; 磯田 勝広; 斎藤 浩美; 石田 功
    日本薬学会年会要旨集, Mar. 2018
    (公社)日本薬学会
  • TNF-α発現・分泌組換えビフィズス菌の構築及び抗腫瘍効果の検討               
    Sep. 2017

Affiliated academic society

  • 2019 - Present
    The Molecular Biology Society of Japan               
  • 2019 - Present
    The Japanese Biochemical Society               
  • 2017 - Present
    The Pharmaceutical Society of Japan               

■University education and qualification information

Qualifications, licenses

  • Pharmacist